(Q38000940)

English

Epithelial to mesenchymal transition in the pathogenesis of uterine malignant mixed Müllerian tumours: the role of ubiquitin proteasome system and therapeutic opportunities

scientific article published on April 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Epithelial to mesenchymal transition in the pathogenesis of uterine malignant mixed Müllerian tumours: the role of ubiquitin proteasome system and therapeutic opportunities (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

ubiquitin-proteasome system

0 references

author name string

I A Voutsadakis

1

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

publication date

1 April 2012

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Clinical and Translational Oncology

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

243-253

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Uterine carcinosarcoma

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

CD133+ cancer stem cell-like cells derived from uterine carcinosarcoma (malignant mixed Müllerian tumor).

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

The epithelial-mesenchymal transition generates cells with properties of stem cells

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Pathology of mixed Müllerian tumours

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas?

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Uterine carcinosarcoma is derived from a single stem cell: an in vitro study

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Characteristics of cloned cells of mixed müllerian tumor of the human uterus carcinoma cells showing myogenic differentiation in vitro

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

p53 overexpression and mutation in metaplastic carcinoma of the breast: genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Metaplastic breast carcinoma: tumour histogenesis or dedifferentiation?

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

The basics of epithelial-mesenchymal transition

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Immunophenotypic features of MELF pattern invasion in endometrial adenocarcinoma: evidence for epithelial-mesenchymal transition.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Unusual Epithelial and Stromal Changes in Myoinvasive Endometrioid Adenocarcinoma: A Study of Their Frequency, Associated Diagnostic Problems, and Prognostic Significance

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Endometrial cells get side-tracked: side population cells promote epithelial-mesenchymal transition in endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Endometrial cancer side-population cells show prominent migration and have a potential to differentiate into the mesenchymal cell lineage

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Ubiquitin networks in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Constructing and decoding unconventional ubiquitin chains.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

The family of ubiquitin-conjugating enzymes (E2s): deciding between life and death of proteins

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Mechanism and function of deubiquitinating enzymes

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Pathogenesis of colorectal carcinoma and therapeutic implications: the roles of the ubiquitin-proteasome system and Cox-2

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

How ubiquitination regulates the TGF-β signalling pathway: new insights and new players: new isoforms of ubiquitin-activating enzymes in the E1-E3 families join the game

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Should grade 3 endometrioid endometrial carcinoma be considered a type 2 cancer-a clinical and pathological evaluation

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Molecular genetic changes in epithelial, stromal and mixed neoplasms of the endometrium

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Requirement of the Akt/beta-catenin pathway for uterine carcinosarcoma genesis, modulating E-cadherin expression through the transactivation of slug

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Expression profiles of carcinosarcoma of the uterine corpus-are these similar to carcinoma or sarcoma?

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Phosphatidylinositol 3-kinase signaling does not activate the wnt cascade

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Crosstalk between NF-kappaB/p65 and beta-catenin/TCF4/p300 signalling pathways through alterations in GSK-3beta expression during trans-differentiation of endometrial carcinoma cells

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

p53 post-translational modification: deregulated in tumorigenesis

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

p21CIP1 attenuates Ras- and c-Myc-dependent breast tumor epithelial mesenchymal transition and cancer stem cell-like gene expression in vivo.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Mutant p53 disrupts MCF-10A cell polarity in three-dimensional culture via epithelial-to-mesenchymal transitions

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Mutant p53(R175H) upregulates Twist1 expression and promotes epithelial-mesenchymal transition in immortalized prostate cells.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Epidermal growth factor receptor and mutant p53 expand an esophageal cellular subpopulation capable of epithelial-to-mesenchymal transition through ZEB transcription factors

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

The ubiquitin ligase COP1 is a critical negative regulator of p53

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

The chaperone-associated ubiquitin ligase CHIP is able to target p53 for proteasomal degradation

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

DNA mismatch repair and TP53 defects are early events in uterine carcinosarcoma tumorigenesis.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Malignant mixed Mullerian tumors of the uterus: histopathological evaluation of cell cycle and apoptotic regulatory proteins

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Mechanism of transcriptional activation by the Myc oncoproteins

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Beta-catenin simultaneously induces activation of the p53-p21WAF1 pathway and overexpression of cyclin D1 during squamous differentiation of endometrial carcinoma cells

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Myc degradation: dancing with ubiquitin ligases.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

IκB kinases increase Myc protein stability and enhance progression of breast cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Overexpression of c-myc induces epithelial mesenchymal transition in mammary epithelial cells

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Estrogen receptor (ER) beta, a modulator of ERalpha in the uterus

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Estrogen receptor-beta: recent lessons from in vivo studies

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Tissue microarray analysis of hormonal signaling pathways in uterine carcinosarcoma

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Development of subtype-selective oestrogen receptor-based therapeutics.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Expression of oestrogen receptors, ERalpha, ERbeta, and ERbeta variants, in endometrial cancers and evidence that prostaglandin F may play a role in regulating expression of ERalpha

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Oestrogen‐induced epithelial–mesenchymal transition of endometrial epithelial cells contributes to the development of adenomyosis

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Estrogen inhibits transforming growth factor beta signaling by promoting Smad2/3 degradation

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Dual effects of TGF-beta on ERalpha-mediated estrogenic transcriptional activity in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

TGFbeta in Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-beta mediated epithelial-mesenchymal transition

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Co-expression of GPR30 and ERbeta and their association with disease progression in uterine carcinosarcoma

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

G protein-coupled receptor 30 in tumor development

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

17-Beta-estradiol inhibits transforming growth factor-beta signaling and function in breast cancer cells via activation of extracellular signal-regulated kinase through the G protein-coupled receptor 30.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Estrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Estrogenic G protein-coupled receptor 30 signaling is involved in regulation of endometrial carcinoma by promoting proliferation, invasion potential, and interleukin-6 secretion via the MEK/ERK mitogen-activated protein kinase pathway

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

[Tamoxifen in the adjuvant setting for breast cancer: Reflexions about the risk of uterine carcinosarcoma].

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Inhibiting proteasomal proteolysis sustains estrogen receptor-alpha activation.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Estrogen-dependent gene transcription in human breast cancer cells relies upon proteasome-dependent monoubiquitination of histone H2B.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

OTU Domain-containing ubiquitin aldehyde-binding protein 1 (OTUB1) deubiquitinates estrogen receptor (ER) alpha and affects ERalpha transcriptional activity

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Role of Ubiquitination in Endocytic Trafficking of G‐Protein‐Coupled Receptors

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Down-modulation of the G-protein-coupled estrogen receptor, GPER, from the cell surface occurs via a trans-Golgi-proteasome pathway

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Regulation of TGF-beta family signaling by E3 ubiquitin ligases

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Smurf2 is a ubiquitin E3 ligase mediating proteasome-dependent degradation of Smad2 in transforming growth factor-beta signaling

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Tumor suppressor Fbxw7 regulates TGFβ signaling by targeting TGIF1 for degradation.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Smad4 protein stability is regulated by ubiquitin ligase SCF beta-TrCP1.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Expression of the ZEB1 (deltaEF1) transcription factor in human: additional insights

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

The transcription factor ZEB1 is aberrantly expressed in aggressive uterine cancers.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

ZEB1 expression in type I vs type II endometrial cancers: a marker of aggressive disease.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Irradiation-induced epithelial-mesenchymal transition (EMT) related to invasive potential in endometrial carcinoma cells

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Deregulation of the HOXA10 homeobox gene in endometrial carcinoma: role in epithelial-mesenchymal transition.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

The E-cadherin repressor snail plays a role in tumor progression of endometrioid adenocarcinomas

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Up-regulation of L1CAM is linked to loss of hormone receptors and E-cadherin in aggressive subtypes of endometrial carcinomas

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Targets of miR-200c mediate suppression of cell motility and anoikis resistance

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

The F-box protein Ppa is a common regulator of core EMT factors Twist, Snail, Slug, and Sip1

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Slug stability is dynamically regulated during neural crest development by the F-box protein Ppa.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

The hypoxia-controlled FBXL14 ubiquitin ligase targets SNAIL1 for proteasome degradation

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Adherens junctions: from molecules to morphogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Adherens junction: molecular architecture and regulation

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Hakai reduces cell-substratum adhesion and increases epithelial cell invasion

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Prognostic impact of alterations in P-cadherin expression and related cell adhesion markers in endometrial cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Gene expression patterns related to vascular invasion and aggressive features in endometrial cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Autocrine motility factor stimulates the invasiveness of malignant cells as well as up-regulation of matrix metalloproteinase-3 expression via a MAPK pathway

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Evidence for the presence of protease-activated receptor 2 and its possible implication in remodeling of human endometrium

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Proteasome inhibitor, bortezomib, for myeloma and lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Emerging role of carfilzomib in treatment of relapsed and refractory lymphoid neoplasms and multiple myeloma.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Therapeutically targeting the SUMOylation, Ubiquitination and Proteasome pathways as a novel anticancer strategy

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Inhibition of proteasome deubiquitinating activity as a new cancer therapy

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

The docking protein p130Cas regulates cell sensitivity to proteasome inhibition

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Molecular predictors of gemcitabine response in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Targeting protein neddylation: a novel therapeutic strategy for the treatment of cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

NUB1 promotes cytoplasmic localization of p53 through cooperation of the NEDD8 and ubiquitin pathways

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Systematic in vivo RNAi analysis identifies IAPs as NEDD8-E3 ligases

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Small-molecule inhibitors of MDM2 as new anticancer therapeutics

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Synthesis and biological evaluation of thio-benzodiazepines as novel small molecule inhibitors of the p53-MDM2 protein-protein interaction

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Direct Evidence for Epithelial-Mesenchymal Transitions in Breast Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0792-4

21 January 2018

Expression and localization of E-cadherin and β-catenin in uterine carcinosarcoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22484631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical expression of E-cadherin and beta-catenin in the normal and malignant human endometrium: an inverse correlation between E-cadherin and nuclear beta-catenin expression

1 reference

https://pubmed.ncbi.nlm.nih.gov/22484631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

GPER mediates the Egr-1 expression induced by 17β-estradiol and 4-hydroxitamoxifen in breast and endometrial cancer cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22484631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative analysis of P16 and P53 expression in uterine malignant mixed mullerian tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/22484631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High Twist expression is involved in infiltrative endometrial cancer and affects patient survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/22484631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical study of DNA topoisomerase I, p53, and Ki-67 in uterine carcinosarcomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/22484631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Myc-modulated miR-9 makes more metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/22484631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential expression of matrix metalloprotease-7 in each component of uterine carcinosarcoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22484631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetics of endometrial cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/22484631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

TGFbeta signaling supports survival and metastasis of endometrial cancer cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22484631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Uterine carcinosarcoma with p53-positive intraepithelial component

1 reference

https://pubmed.ncbi.nlm.nih.gov/22484631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epithelial to mesenchymal transition in early stage endometrioid endometrial carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22484631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22484631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

G-protein-coupled estrogen receptor GPR30 and tamoxifen resistance in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22484631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular genetic aberrations of ovarian and uterine carcinosarcomas--a CGH and FISH study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22484631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carcinosarcomas of the female genital tract. A pathologic study of 29 metastatic tumors: further evidence for the dominant role of the epithelial component and the conversion theory of histogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22484631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Coordinate expression of Cdc25B and ER-alpha is frequent in low-grade endometrioid endometrial carcinoma but uncommon in high-grade endometrioid and nonendometrioid carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/22484631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

GPR30: a novel indicator of poor survival for endometrial carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22484631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alteration of CD44 and cadherins expression: possible association with augmented aggressiveness and invasiveness of endometrial carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22484631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mutant p53 gain of function is interwoven into the hallmarks of cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22484631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation between invasive pattern and immunophenotypic alterations in endocervical adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22484631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22484631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12094-012-0792-4

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38000940&oldid=2201157699"